Renal Cancers Completed Phase 2 Trials for Gefitinib (DB00317)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00012337ZD 1839 in Treating Patients With Metastatic Kidney CancerTreatment
NCT00014183ZD 1839 in Treating Patients With Stage IV or Recurrent Kidney CancerTreatment
NCT00467077Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney CancerTreatment